About 537 million adults worldwide live with diabetes, and 90-95% of these cases are type 2 diabetes. People with diabetes are at increased risk of many health problems, including eye problems. These include diabetic retinopathy trusted source, diabetic macular edema, glaucoma, cataract trusted source, chronic dry eye, and retinal detachment. There is currently no cure for diabetic retinopathy or diabetic macular edema. Current treatment options for both conditions include drugs injected directly into the eye, laser treatment, and eye surgery. Soon, less invasive treatment for diabetic retinopathy and diabetic macular edema may be available in the form of eye drops.<\/p>\n\n\n\n
Recently released data from a phase 1b\/2a trial of the new treatment showed it to be safe and tolerable, with 100% of participants completing the study. Additionally, the researchers reported a significant reduction in central macular thickness and prevention of further increases in vascular leakage after 85 days of use.<\/p>\n\n\n\n
The current standard of care for diabetic macular edema involves anti-VEGF agents in the eye, so new approaches to treating diabetic retinopathy and diabetic macular edema are required, according to the study’s presenting author and manufacturer of new eye drops. entails several injections, which are painful and need clinical time to complete even though they are effective.
A non-invasive approach is required to enhance these patients’ quality of life by promoting comfort and lowering pain levels through self-management. According to Dr. Lhuillier, patients with non-proliferative diabetic retinopathy in the early stages of the condition are not given a treatment option other than to wait for their symptoms to get better. It’s possible that the condition won’t worsen due to proliferative diabetic retinopathy. When the patient’s condition reaches an advanced stage or they develop diabetic macular edema, anti-VEGF injections are recommended. He said that treating diabetic retinopathy patients with non-invasive, safe, and effective therapies early on will help stop the condition from getting worse. About 7 and a half million Americans are thought to have non-proliferative diabetic retinopathy, and another 1 and a half million have advanced the disease to more severe forms, which hasten its progression and deteriorates vision. There is a strong motivation to cut back. Dangerous complications.<\/p>\n\n\n\n
According to reports, the novel\u00a0eye drop,\u00a0known as\u00a0EXN407, is the first topical treatment for retinal vascular\u00a0conditions like\u00a0diabetic macular\u00a0edema and diabetic retinopathy. The\u00a0eye drop is a\u00a0small molecule treatment that employs an inhibitor of\u00a0serine-arginine protein kinase 1\u00a0(SRPK1). Numerous factors contribute to the\u00a0development of diabetic eye\u00a0disease, but the primary cause\u00a0is the overgrowth of blood vessels in the\u00a0retina.\u00a0These blood vessels\u00a0eventually leak, causing\u00a0subretinal\u00a0edema to appear\u00a0and\u00a0blindness to result. VEGFTrusted Source\u00a0is a growth factor\u00a0that causes this phenomenon. According to him,\u00a0EXN407 is a molecule that only\u00a0inhibits\u00a0the members of the family\u00a0that cause disease,\u00a0leaving the non-disease-causing members intact,\u00a0allowing the VEGF to be balanced again. In addition to being more convenient as an eyedrop formulation as opposed to an injection, it provides\u00a0a more\u00a0nuanced\u00a0approach than anti-VEGF\u00a0agents.<\/p>\n\n\n\n
https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332218346705 Medications that have been suggested by doctors worldwide are available here About 537 million adults worldwide live with diabetes, and 90-95% of these cases are type 2 diabetes. People with diabetes are at increased risk of many health problems, including eye problems. These include diabetic retinopathy trusted source, diabetic macular edema, glaucoma, cataract trusted source, chronic dry eye, and retinal detachment. There is currently no cure for diabetic retinopathy or diabetic macular edema. Current treatment options for both conditions include drugs injected directly into the eye, laser treatment, and eye surgery….<\/p>\n
https:\/\/www.aao.org\/eye-health\/diseases\/what-is-diabetic-retinopathy
https:\/\/my.clevelandclinic.org\/health\/diseases\/8591-diabetic-retinopathy
https:\/\/www.medicalnewstoday.com\/articles\/could-an-intervention-as-simple-as-eye-drops-treat-eye-damage-in-diabetes#Improvements-in-macular-thickness,-vascular-leakage<\/a><\/p>\n\n\n\n
https:\/\/mygenericpharmacy.com\/index.php?therapy=75<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"